ArticleBlood2012

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.

Zijun Y Xu-Monette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.